The total return over the past 12 months is -36.70% vs. +16.94% for the S&P 500. So far it's up -30.32% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (36.70%) | (25.38%) | (37.32%) | N/A | N/A | N/A |
| Total Return CAGR | (36.70%) | (25.38%) | (37.32%) | N/A | N/A | N/A |
| Revenue CAGR | (13.15%) | (8.61%) | +1.46% | +11.39% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MaxCyte, Inc. (MXCT)
| Year | Start price | End price | MXCT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.55 | $1.08 | (30.32%) | +14.51% | (44.83%) |
| 2025 | $4.16 | $1.55 | (62.74%) | +17.72% | (80.46%) |
| 2024 | $4.70 | $4.16 | (11.49%) | +24.89% | (36.38%) |
| 2023 | $5.46 | $4.70 | (13.92%) | +26.19% | (40.11%) |
| 2022 | $10.19 | $5.46 | (46.42%) | (18.17%) | (28.25%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
